Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis
NCT01659242Phase 4Terminated
- Sponsor
- Singapore General Hospital
- Start
- Jul 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of leflunomide, 5-aminosalicylic acid + sulphasalazine in rheumatoid arthritis (RA), sponsored by Singapore General Hospital. Started Jul 2012; status: terminated.
02
Drugs
leflunomide5-aminosalicylic acid + sulphasalazine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01659242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01659242.